Presentation TCT 2017 Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR? Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis? Presenter: David H. Adams, Ted Feldman, Craig R. Smith October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients? Presenter: C. Michael Gibson, Stephan Windecker October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds? Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy? Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI? Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith October 30, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News TCT 2016 No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low Shelley Wood November 07, 2016
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
News Conference News TCT 2016 Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties Yael L. Maxwell November 02, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Direct Annuloplasty II: Mitralign Trial Results and Future Directions Presenter: Ted Feldman, Scott Lim, Azeem Latib October 31, 2016
Presentation TCT 2016 Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions Presenter: Ted Feldman, Scott Lim, Francesco Maisano October 31, 2016
Presentation TCT 2016 Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello October 31, 2016
Presentation TCT 2016 Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff October 31, 2016
Presentation TCT 2016 Rationale for and Design of GALILEO Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja October 31, 2016
Presentation TCT 2016 Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara October 31, 2016